MARLVEL

Libre by Abbott vs its rivals

Side-by-side comparison against Libre by Abbott's closest competitors — identity, store metrics, ratings & sentiment, and strategic intel.

Libre by Abbott
This App
mySugr - Diabetes Tracker Log
Nemesis
Glucose Buddy Diabetes Tracker
Contender
OneTouch Reveal® app
Contender
Dexcom G7
Contender
Kardia
Peer
Medisafe Medication Management
Peer
One Medical
New Kid
Sword Health: AI Care
New Kid
Core Identity
DeveloperAbbott LabsmySugr GmbHAzumio Inc.LifeScan, Inc.DexcomAliveCor, Inc.MediSafe Inc.One Medical Group, Inc.Sword Health, Inc
CategoryMedicalMedicalMedicalMedicalMedicalMedicalMedicalMedicalMedical
PlatformiOS, AndroidiOS, AndroidiOS, AndroidAndroid, iOSAndroid, iOSiOS, AndroidiOSiOS, AndroidiOS, Android
Store Metrics
Rating4.6 / 54.7 / 54.8 / 54.8 / 53.1 / 54.8 / 54.7 / 54.9 / 54.7 / 5
Ratings Count105,45930,73124,578157,9647,602210,89599,62652,71243,038
PriceFreeFreeFreeFreeFreeFreeFreeFreeFree
Release DateMar 31, 2025Jun 3, 2013Oct 28, 2008Nov 8, 2013Feb 13, 2023Jan 6, 2013Nov 8, 2012Sep 27, 2010Sep 10, 2019
Last UpdatedJan 16, 2026Apr 12, 2026Apr 26, 2026Dec 4, 2025Mar 19, 2026Apr 15, 2026Feb 10, 2026Apr 13, 2026Apr 11, 2026
Sentiment & Reviews
Sentimentmixed-terrible---terrible-mixed
Score45/100-15/100---25/100-45/100
Praises
  • Real-time glucose monitoring provides freedom from manual finger-prick testing throughout the day
-
  • Comprehensive health tracking features allow users to monitor glucose and blood pressure effectively
---
  • Reliable medication reminders provide essential daily support for managing complex health schedules
-
  • Personalized physical therapy programs delivered at home provide measurable pain relief and mobility improvements
Complaints
  • Frequent Bluetooth connection drops between the sensor and mobile device disrupt continuous data tracking
-
  • Persistent application crashes and loading failures prevent access to critical health data
  • Aggressive subscription prompts and paywalls frustrate users attempting to access basic functionality
---
  • Frequent application crashes and interface freezes prevent users from logging medication doses
  • Aggressive transition to a paid subscription model locks users out of existing data
-
  • Aggressive and invasive communication tactics across multiple channels overwhelm users with excessive notifications and calls
Requests
  • Integration with Apple Health is requested to centralize glucose data with other health metrics
-
  • Seamless integration with third-party health platforms for data synchronization and backup
-----
  • Consolidated device and application usage to eliminate the need for secondary hardware or multiple logins
Strategic Intel
Strengths
  • Proprietary sensor-hardware integration creates high switching costs
  • LibreView clinical data management drives provider-led prescription volume
-
  • 15-year market presence builds significant trust
  • Direct hardware integration creates high switching costs
---
  • Clinical-grade drug interaction engine
  • Deep integration with US health infrastructure
  • Multi-user family sync
-
  • FDA-listed device certification validates clinical efficacy
  • AI-human hybrid model scales therapy access
  • Outcome-based pricing aligns with enterprise cost-reduction
Weaknesses
  • Frequent Bluetooth connection drops
  • Lack of Apple Health data syncing
  • 0.7★ Android-iOS rating gap
-
  • 2.25★ Android rating vs 4.8★ iOS rating
  • Persistent launch-time crashes on latest versions
  • Unresponsive customer support for billing issues
---
  • High crash frequency post-update
  • Mandatory paywall for historical data
  • Inconsistent notification reliability
-
  • Aggressive multi-channel notification intensity
  • Hardware pairing failures in the latest release
  • Multi-step login friction across devices
Pricingfreefreemiumsubscriptionfreefreefreemiumfreemiumsubscriptionfree
Momentum-IntenseMaintenanceSteadyIntenseIntenseActiveIntenseIntense
Update Cadence-5 versions3 versions, ~325d avg5 versions5 versions5 versions5 versions, ~11d avg5 versions5 versions

Compare Libre by Abbott head-to-head

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Libre by Abbott, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

See methodologyContact support

Data licensed under CC-BY-NC 4.0